NIOX Group Plc (LON:NIOX – Get Free Report)’s stock price was up 1.7% during mid-day trading on Wednesday . The company traded as high as GBX 62 ($0.78) and last traded at GBX 61.40 ($0.77). Approximately 198,762 shares changed hands during mid-day trading, a decline of 79% from the average daily volume of 928,731 shares. The stock had previously closed at GBX 60.40 ($0.76).
NIOX Group Trading Up 1.3 %
The company has a 50-day moving average price of GBX 63.88 and a 200 day moving average price of GBX 65.76. The stock has a market capitalization of £269.75 million, a P/E ratio of 3,180.00 and a beta of 0.92. The company has a current ratio of 6.32, a quick ratio of 1.94 and a debt-to-equity ratio of 1.10.
Insiders Place Their Bets
In other news, insider Garry Watts sold 27,109 shares of the stock in a transaction on Friday, October 25th. The stock was sold at an average price of GBX 80 ($1.01), for a total transaction of £21,687.20 ($27,372.46). 46.72% of the stock is currently owned by corporate insiders.
NIOX Group Company Profile
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.
Featured Articles
- Five stocks we like better than NIOX Group
- Do ETFs Pay Dividends? What You Need to Know
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- 10 Best Airline Stocks to Buy
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Low PE Growth Stocks: Unlocking Investment Opportunities
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.